90729-41-2

90729-41-2结构式
90729-41-2结构式
  • 常用中文名:奥索地平
  • 常用英文名:Oxodipine
  • CAS号:90729-41-2
  • 分子式:C19H21NO6
  • 分子量:359.37300
  • 发布时间:2018-06-03 08:00:00
  • 更新时间:2024-01-19 11:39:08

化源商城直购

中文名 奥索地平
英文名 5-O-ethyl 3-O-methyl 4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
英文别名 Oxodipinum
IQB-837-V
Oxodipino [Spanish]
Oxodipinum [Latin]
Oxodipine [INN]
3,5-Pyridinedicarboxylic acid,1,4-dihydro-4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-,ethyl methyl ester
Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(2,3-(methylenedioxy)phenyl)-3,5-pyridinedicarboxylate
OXODIPINE
Oxodipino
密度 1.247g/cm3
沸点 470ºC at 760 mmHg
分子式 C19H21NO6
分子量 359.37300
闪点 238ºC
精确质量 359.13700
PSA 83.09000
LogP 2.71500
折射率 1.552

CHEMICAL IDENTIFICATION

RTECS NUMBER :
US7968500
CHEMICAL NAME :
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-, ethyl methyl ester
CAS REGISTRY NUMBER :
90729-41-2
LAST UPDATED :
199406
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C19-H21-N-O6
MOLECULAR WEIGHT :
359.41

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 12,633,1987
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- Volume(issue)/page/year: 54(2),40,1991 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
2160 mg/kg/13W-I
TOXIC EFFECTS :
Vascular - BP lowering not characterized in autonomic section Endocrine - other changes Endocrine - changes in adrenal weight
REFERENCE :
TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 20,549,1992